Sandy Spring Bank’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$5.41M Buy
216,387
+13,406
+7% +$332K 0.23% 100
2024
Q4
$4.99M Buy
202,981
+9,751
+5% +$244K 0.2% 105
2024
Q3
$4.97M Buy
193,230
+33,241
+21% +$839K 0.2% 107
2024
Q2
$3.93M Buy
159,989
+25,530
+19% +$624K 0.17% 118
2024
Q1
$3.34M Buy
134,459
+20,427
+18% +$506K 0.15% 132
2023
Q4
$2.88M Buy
114,032
+20,032
+21% +$478K 0.14% 135
2023
Q3
$2.21M Buy
94,000
+45,935
+96% +$1.11M 0.12% 145
2023
Q2
$1.18M Buy
48,065
+28,905
+151% +$716K 0.06% 196
2023
Q1
$480K Buy
19,160
+12,890
+206% +$319K 0.03% 256
2022
Q4
$152K Buy
+6,270
New +$151K 0.01% 368

Other funds holding IBDX

Sandy Spring Bank's IBDX Position: Q1 2025 in Review

Sandy Spring Bank increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 6.6% in Q1 2025, buying an estimated $332K and bringing the position to 216,387 shares worth $5.41M. The position accounts for 0.23% of the portfolio, ranked #100.

Sandy Spring Bank first reported a position in IBDX in Q4 2022 and has held it in 10 quarters since. 141 funds tracked by Wall St. Rank hold IBDX as of Q1 2025.

  • Sandy Spring Bank held 216,387 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $5.41M as of Q1 2025.
  • Sandy Spring Bank bought 13,406 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2025, an estimated $332K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.23% of Sandy Spring Bank's portfolio in Q1 2025, its #100 holding.
  • Sandy Spring Bank first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2022 and has held it in 10 quarters since.
  • 141 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.